Do comorbidities decrease the first tnf-inhibitor retention and treatment response in axial spondyloarthritis patients? Data from Turkbio

Erez, Y.Karakaş, A.Kocaer, S. B.İnel, T. YüceGülle, S.Avşar, A. KökenUslu, S.Can, G.Sarı, I.Birlik, M.Dalkılıç, E.Pehlivan, Y.Şenel, S.Akar, S.Koca, S. S.Tufan, A.Yazıcı, A.Yılmaz, S.İnanç, N.Solmaz, D.Akkoç, N.Önen, F.TURKBIO Study Group2024-07-042024-07-042020-06-010003-4967https://doi.org/10.1136/annrheumdis-2020-eular.2925https://ard.bmj.com/content/79/Suppl_1/422https://hdl.handle.net/11452/42872enScience & technologyLife sciences & biomedicineRheumatologyDo comorbidities decrease the first tnf-inhibitor retention and treatment response in axial spondyloarthritis patients? Data from TurkbioMeeting Abstract0005559050012224184197910.1136/annrheumdis-2020-eular.2925